http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
http://fasb.org/us-gaap/2024#RestructuringCharges
http://fasb.org/us-gaap/2024#RestructuringCharges
http://fasb.org/us-gaap/2024#RestructuringCharges
http://fasb.org/us-gaap/2024#RestructuringCharges
http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent
http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
http://fasb.org/us-gaap/2024#OtherAssetsCurrent
http://fasb.org/us-gaap/2024#OtherAssetsCurrent
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
http://fasb.org/us-gaap/2024#OtherAssetsCurrent
http://fasb.org/us-gaap/2024#OtherAssetsCurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
33.33
33.33
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
mrk:segment
mrk:aqua_facility
xbrli:pure
mrk:antibodyDrugConjugate
mrk:candidate
mrk:jurisdiction
mrk:interest_rate_swap
iso4217:EUR
mrk:case
mrk:Plaintiff
mrk:motion
mrk:patent
0000310158
2024-01-01
2024-12-31
0000310158
us-gaap:CommonStockMember
2024-01-01
2024-12-31
0000310158
mrk:A1.875Notesdue2026Member
2024-01-01
2024-12-31
0000310158
mrk:A3.250NotesDue2032Member
2024-01-01
2024-12-31
0000310158
mrk:A2.500Notesdue2034Member
2024-01-01
2024-12-31
0000310158
mrk:A1.375Notesdue2036Member
2024-01-01
2024-12-31
0000310158
mrk:A3.500NotesDue2037Member
2024-01-01
2024-12-31
0000310158
mrk:A3.700NotesDue2044Member
2024-01-01
2024-12-31
0000310158
mrk:A3.750NotesDue2054Member
2024-01-01
2024-12-31
0000310158
2025-01-31
0000310158
2024-06-28
0000310158
2023-01-01
2023-12-31
0000310158
2022-01-01
2022-12-31
0000310158
2024-12-31
0000310158
2023-12-31
0000310158
us-gaap:CommonStockMember
2021-12-31
0000310158
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0000310158
us-gaap:RetainedEarningsMember
2021-12-31
0000310158
us-